OncoBayes2 (Q52525): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Swh import (talk | contribs)
SWHID from Software Heritage
 
(30 intermediate revisions by 3 users not shown)
Property / last update
3 March 2023
Timestamp+2023-03-03T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / last update: 3 March 2023 / rank
Normal rank
 
Property / author
 
Property / author: Lukas A. Widmer / rank
Normal rank
 
Property / author
 
Property / author: Andrew Bean / rank
Normal rank
 
Property / copyright license
 
Property / copyright license: GNU General Public License / rank
Normal rank
 
Property / copyright license: GNU General Public License / qualifier
edition/version: ≥ 3 (English)
 
Property / imports
 
Property / imports: methods / rank
Normal rank
 
Property / imports
 
Property / imports: ggplot2 / rank
Normal rank
 
Property / imports: ggplot2 / qualifier
 
Property / imports
 
Property / imports: tidyselect / rank
Normal rank
 
Property / imports
 
Property / imports: utils / rank
Normal rank
 
Property / imports
 
Property / imports: stats / rank
Normal rank
 
Property / imports
 
Property / imports: Rcpp / rank
Normal rank
 
Property / imports
 
Property / imports: RcppParallel / rank
Normal rank
 
Property / imports
 
Property / imports: rstan / rank
Normal rank
 
Property / imports
 
Property / imports: rstantools / rank
Normal rank
 
Property / imports
 
Property / imports: posterior / rank
Normal rank
 
Property / imports
 
Property / imports: assertthat / rank
Normal rank
 
Property / imports
 
Property / imports: checkmate / rank
Normal rank
 
Property / imports
 
Property / imports: Formula / rank
Normal rank
 
Property / imports
 
Property / imports: bayesplot / rank
Normal rank
 
Property / imports
 
Property / imports: dplyr / rank
Normal rank
 
Property / imports
 
Property / imports: tibble / rank
Normal rank
 
Property / imports
 
Property / imports: tidyr / rank
Normal rank
 
Property / imports
 
Property / imports: abind / rank
Normal rank
 
Property / imports
 
Property / imports: scales / rank
Normal rank
 
Property / imports
 
Property / imports: rlang / rank
Normal rank
 
Property / imports
 
Property / imports: matrixStats / rank
Normal rank
 
Property / cites work
 
Property / cites work: Critical aspects of the Bayesian approach to phase I cancer trials / rank
Normal rank
 
Property / cites work
 
Property / cites work: On the Use of Co-Data in Clinical Trials / rank
Normal rank
 
Property / depends on software
 
Property / depends on software: R / rank
Normal rank
 
Property / software version identifier
 
0.4-4
Property / software version identifier: 0.4-4 / rank
 
Normal rank
Property / software version identifier: 0.4-4 / qualifier
 
publication date: 29 August 2019
Timestamp+2019-08-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.5-3
Property / software version identifier: 0.5-3 / rank
 
Normal rank
Property / software version identifier: 0.5-3 / qualifier
 
publication date: 15 November 2019
Timestamp+2019-11-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.5-4
Property / software version identifier: 0.5-4 / rank
 
Normal rank
Property / software version identifier: 0.5-4 / qualifier
 
publication date: 19 November 2019
Timestamp+2019-11-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.5-8
Property / software version identifier: 0.5-8 / rank
 
Normal rank
Property / software version identifier: 0.5-8 / qualifier
 
publication date: 12 December 2019
Timestamp+2019-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.6-0
Property / software version identifier: 0.6-0 / rank
 
Normal rank
Property / software version identifier: 0.6-0 / qualifier
 
publication date: 11 February 2020
Timestamp+2020-02-11T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.6-3
Property / software version identifier: 0.6-3 / rank
 
Normal rank
Property / software version identifier: 0.6-3 / qualifier
 
publication date: 19 March 2020
Timestamp+2020-03-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.6-4
Property / software version identifier: 0.6-4 / rank
 
Normal rank
Property / software version identifier: 0.6-4 / qualifier
 
publication date: 7 April 2020
Timestamp+2020-04-07T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.6-5
Property / software version identifier: 0.6-5 / rank
 
Normal rank
Property / software version identifier: 0.6-5 / qualifier
 
publication date: 7 May 2020
Timestamp+2020-05-07T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.7-0
Property / software version identifier: 0.7-0 / rank
 
Normal rank
Property / software version identifier: 0.7-0 / qualifier
 
publication date: 7 May 2021
Timestamp+2021-05-07T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-1
Property / software version identifier: 0.8-1 / rank
 
Normal rank
Property / software version identifier: 0.8-1 / qualifier
 
publication date: 2 September 2021
Timestamp+2021-09-02T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-2
Property / software version identifier: 0.8-2 / rank
 
Normal rank
Property / software version identifier: 0.8-2 / qualifier
 
publication date: 14 September 2021
Timestamp+2021-09-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-4
Property / software version identifier: 0.8-4 / rank
 
Normal rank
Property / software version identifier: 0.8-4 / qualifier
 
publication date: 18 February 2022
Timestamp+2022-02-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-5
Property / software version identifier: 0.8-5 / rank
 
Normal rank
Property / software version identifier: 0.8-5 / qualifier
 
publication date: 1 March 2022
Timestamp+2022-03-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-6
Property / software version identifier: 0.8-6 / rank
 
Normal rank
Property / software version identifier: 0.8-6 / qualifier
 
publication date: 2 May 2022
Timestamp+2022-05-02T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-7
Property / software version identifier: 0.8-7 / rank
 
Normal rank
Property / software version identifier: 0.8-7 / qualifier
 
publication date: 25 August 2022
Timestamp+2022-08-25T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.8-9
Property / software version identifier: 0.8-9 / rank
 
Normal rank
Property / software version identifier: 0.8-9 / qualifier
 
publication date: 20 July 2023
Timestamp+2023-07-20T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / last update
 
20 July 2023
Timestamp+2023-07-20T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / last update: 20 July 2023 / rank
 
Normal rank
Property / description
 
Bayesian logistic regression model with optional EXchangeability-NonEXchangeability parameter modelling for flexible borrowing from historical or concurrent data-sources. The safety model can guide dose-escalation decisions for adaptive oncology Phase I dose-escalation trials which involve an arbitrary number of drugs. Please refer to Neuenschwander et al. (2008) <doi:10.1002/sim.3230> and Neuenschwander et al. (2016) <doi:10.1080/19466315.2016.1174149> for details on the methodology.
Property / description: Bayesian logistic regression model with optional EXchangeability-NonEXchangeability parameter modelling for flexible borrowing from historical or concurrent data-sources. The safety model can guide dose-escalation decisions for adaptive oncology Phase I dose-escalation trials which involve an arbitrary number of drugs. Please refer to Neuenschwander et al. (2008) <doi:10.1002/sim.3230> and Neuenschwander et al. (2016) <doi:10.1080/19466315.2016.1174149> for details on the methodology. / rank
 
Normal rank
Property / author
 
Property / author: Sebastian Weber / rank
 
Normal rank
Property / author
 
Property / author: Lukas A. Widmer / rank
 
Normal rank
Property / author
 
Property / author: Andrew Bean / rank
 
Normal rank
Property / copyright license
 
Property / copyright license: GNU General Public License / rank
 
Normal rank
Property / copyright license: GNU General Public License / qualifier
 
edition/version: ≥ 3 (English)
Property / depends on software
 
Property / depends on software: R / rank
 
Normal rank
Property / depends on software: R / qualifier
 
Property / imports
 
Property / imports: methods / rank
 
Normal rank
Property / imports
 
Property / imports: Rcpp / rank
 
Normal rank
Property / imports: Rcpp / qualifier
 
Property / imports
 
Property / imports: RcppParallel / rank
 
Normal rank
Property / imports: RcppParallel / qualifier
 
Property / imports
 
Property / imports: rstan / rank
 
Normal rank
Property / imports: rstan / qualifier
 
Property / imports
 
Property / imports: rstantools / rank
 
Normal rank
Property / imports: rstantools / qualifier
 
Property / imports
 
Property / imports: posterior / rank
 
Normal rank
Property / imports: posterior / qualifier
 
Property / imports
 
Property / imports: assertthat / rank
 
Normal rank
Property / imports: assertthat / qualifier
 
Property / imports
 
Property / imports: checkmate / rank
 
Normal rank
Property / imports
 
Property / imports: Formula / rank
 
Normal rank
Property / imports
 
Property / imports: bayesplot / rank
 
Normal rank
Property / imports: bayesplot / qualifier
 
Property / imports
 
Property / imports: ggplot2 / rank
 
Normal rank
Property / imports: ggplot2 / qualifier
 
Property / imports
 
Property / imports: dplyr / rank
 
Normal rank
Property / imports: dplyr / qualifier
 
Property / imports
 
Property / imports: tibble / rank
 
Normal rank
Property / imports
 
Property / imports: tidyr / rank
 
Normal rank
Property / imports: tidyr / qualifier
 
Property / imports
 
Property / imports: abind / rank
 
Normal rank
Property / imports
 
Property / imports: scales / rank
 
Normal rank
Property / imports
 
Property / imports: rlang / rank
 
Normal rank
Property / imports: rlang / qualifier
 
Property / imports
 
Property / imports: tidyselect / rank
 
Normal rank
Property / imports
 
Property / imports: utils / rank
 
Normal rank
Property / imports
 
Property / imports: stats / rank
 
Normal rank
Property / imports
 
Property / imports: matrixStats / rank
 
Normal rank
Property / cites work
 
Property / cites work: Critical aspects of the Bayesian approach to phase I cancer trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: On the Use of Co-Data in Clinical Trials / rank
 
Normal rank
Property / source code repository
 
Property / source code repository: https://github.com/cran/OncoBayes2 / rank
 
Normal rank
Property / Software Heritage ID
 
Property / Software Heritage ID: swh:1:snp:d9a2dc45a343cd68fc140be86cacebc6c0b79661 / rank
 
Normal rank
Property / Software Heritage ID: swh:1:snp:d9a2dc45a343cd68fc140be86cacebc6c0b79661 / qualifier
 
Property / Software Heritage ID: swh:1:snp:d9a2dc45a343cd68fc140be86cacebc6c0b79661 / qualifier
 
point in time: 17 August 2023
Timestamp+2023-08-17T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
links / mardi / namelinks / mardi / name
 

Latest revision as of 03:33, 22 March 2024

Bayesian Logistic Regression for Oncology Dose-Escalation Trials
Language Label Description Also known as
English
OncoBayes2
Bayesian Logistic Regression for Oncology Dose-Escalation Trials

    Statements

    0 references
    0 references
    0.8-8
    3 March 2023
    0 references
    0.4-4
    29 August 2019
    0 references
    0.5-3
    15 November 2019
    0 references
    0.5-4
    19 November 2019
    0 references
    0.5-8
    12 December 2019
    0 references
    0.6-0
    11 February 2020
    0 references
    0.6-3
    19 March 2020
    0 references
    0.6-4
    7 April 2020
    0 references
    0.6-5
    7 May 2020
    0 references
    0.7-0
    7 May 2021
    0 references
    0.8-1
    2 September 2021
    0 references
    0.8-2
    14 September 2021
    0 references
    0.8-4
    18 February 2022
    0 references
    0.8-5
    1 March 2022
    0 references
    0.8-6
    2 May 2022
    0 references
    0.8-7
    25 August 2022
    0 references
    0.8-9
    20 July 2023
    0 references
    0 references
    0 references
    20 July 2023
    0 references
    Bayesian logistic regression model with optional EXchangeability-NonEXchangeability parameter modelling for flexible borrowing from historical or concurrent data-sources. The safety model can guide dose-escalation decisions for adaptive oncology Phase I dose-escalation trials which involve an arbitrary number of drugs. Please refer to Neuenschwander et al. (2008) <doi:10.1002/sim.3230> and Neuenschwander et al. (2016) <doi:10.1080/19466315.2016.1174149> for details on the methodology.
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references